Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia.
Lucena-Araujo AR, Kim HT, Thomé C, Jacomo RH, Melo RA, Bittencourt R, Pasquini R, Pagnano K, Glória AB, Chauffaille Mde L, Athayde M, Chiattone CS, Mito I, Bendlin R, Souza C, Bortolheiro C, Coelho-Silva JL, Schrier SL, Tallman MS, Grimwade D, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Sanz MA, Rego EM. Lucena-Araujo AR, et al. Among authors: mito i. Blood. 2015 Nov 12;126(20):2302-6. doi: 10.1182/blood-2015-01-623330. Epub 2015 Oct 1. Blood. 2015. PMID: 26429976 Free PMC article. Clinical Trial.
High prevalence of anemia in children and adult women in an urban population in southern Brazil.
Silla LM, Zelmanowicz A, Mito I, Michalowski M, Hellwing T, Shilling MA, Friedrisch JR, Bittar CM, Albrecht CA, Scapinello E, Conti C, Albrecht MA, Baggio L, Pezzi A, Amorin B, Valim V, Fogliatto L, Paz A, Astigarraga C, Bittencourt RI, Fischer G, Daudt L. Silla LM, et al. Among authors: mito i. PLoS One. 2013 Jul 29;8(7):e68805. doi: 10.1371/journal.pone.0068805. Print 2013. PLoS One. 2013. PMID: 23922664 Free PMC article.
Dynamic alterations of circulating T lymphocytes and the clinical response in patients with head and neck squamous cell carcinoma treated with nivolumab.
Tada H, Takahashi H, Yamada K, Masuda K, Nagata Y, Uchida M, Shino M, Ida S, Mito I, Matsuyama T, Oyama T, Tatematsu KI, Sezutsu H, Takeda S, Chikamatsu K. Tada H, et al. Among authors: mito i. Cancer Immunol Immunother. 2022 Apr;71(4):851-863. doi: 10.1007/s00262-021-03042-y. Epub 2021 Aug 31. Cancer Immunol Immunother. 2022. PMID: 34463793 Free PMC article.
14 results